_id
6915ee53bc934aba376b1e99
Ticker
RGC
Name
Regencell Bioscience Holdings Ltd
Exchange
NASDAQ
Address
Chinachem Leighton Plaza, Causeway Bay, Hong Kong
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.regencellbioscience.com
Description
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Last Close
24.17
Volume
1855566
Current Price
32.54
Change
6.5
Last Updated
2026-01-06T10:12:50.531Z
Image
data:image/webp;base64,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
Ipo Date
2021-07-16T00:00:00.000Z
Market Cap
10156802048
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.89425
Sentiment Sources
4
Current Quarter
2025-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1792150
Operating Income
-1792150
Interest Expense
-
Pretax Income
-1730600
Net Income
-1730600
Eps
-0.00349977516583648
Dividends Per Share
-
Shares Outstanding
494488908
Income Tax Expense
-
EBITDA
-1730600
Operating Margin
-
Total Other Income Expense Net
61550
Cash
2419115
Short Term Investments
2477900
Receivables
-
Inventories
-
Total Current Assets
4902813
Property Plant Equipment
759819
Total Assets
5755582
Payables
-
Short Term Debt
312780
Long Term Debt
-
Total Liabilities
895308
Equity
4860274
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
3310.6506065954304
ROE
-35.6070460225082
ROA
-30.06820161714315
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
34
Deep Value Investing Score
3
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1792150
Quarters > 0 > income Statement > operating Income
-1792150
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1730600
Quarters > 0 > income Statement > net Income
-1730600
Quarters > 0 > income Statement > eps
-0.00349977516583648
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
494488908
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1730600
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
61550
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2419115
Quarters > 0 > balance Sheet > short Term Investments
2477900
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4902813
Quarters > 0 > balance Sheet > property Plant Equipment
759819
Quarters > 0 > balance Sheet > total Assets
5755582
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
312780
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
895308
Quarters > 0 > balance Sheet > equity
4860274
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00349977516583648
Quarters > 0 > ratios > PB
3310.6506065954304
Quarters > 0 > ratios > ROE
-35.6070460225082
Quarters > 0 > ratios > ROA
-30.06820161714315
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1977835
Quarters > 1 > income Statement > operating Income
-1977835
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1853613
Quarters > 1 > income Statement > net Income
-1853613
Quarters > 1 > income Statement > eps
-0.14244463902110419
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13012866
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1777170
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
124222
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
6586450
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
7479191
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
763839
Quarters > 1 > balance Sheet > equity
6715352
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1852
Quarters > 1 > cash Flow > depreciation
76445
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.14244463902110419
Quarters > 1 > ratios > PB
63.05531856557929
Quarters > 1 > ratios > ROE
-27.60261859691048
Quarters > 1 > ratios > ROA
-24.783602932456198
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
988918
Quarters > 2 > income Statement > operating Income
-988918
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-926807
Quarters > 2 > income Statement > net Income
-926807
Quarters > 2 > income Statement > eps
-0.0018742760188315995
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
494488000
Quarters > 2 > income Statement > income Tax Expense
57887
Quarters > 2 > income Statement > EBITDA
-912473
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
62111
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
2961235
Quarters > 2 > balance Sheet > short Term Investments
5000000
Quarters > 2 > balance Sheet > receivables
152778
Quarters > 2 > balance Sheet > inventories
-152778
Quarters > 2 > balance Sheet > total Current Assets
6586450
Quarters > 2 > balance Sheet > property Plant Equipment
226514
Quarters > 2 > balance Sheet > total Assets
7479191
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
119614
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
763839
Quarters > 2 > balance Sheet > equity
6715352
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-926
Quarters > 2 > cash Flow > depreciation
76445
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0018742760188315995
Quarters > 2 > ratios > PB
2396.0977056749966
Quarters > 2 > ratios > ROE
-13.801316744081324
Quarters > 2 > ratios > ROA
-12.391808151443119
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1212
Quarters > 3 > income Statement > operating Income
-1212
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1088
Quarters > 3 > income Statement > net Income
-1117
Quarters > 3 > income Statement > eps
-0.000002258973156065838
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
494472454
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1139
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
123.77
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2961235
Quarters > 3 > balance Sheet > short Term Investments
5000000
Quarters > 3 > balance Sheet > receivables
152778
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
8114013
Quarters > 3 > balance Sheet > property Plant Equipment
226514
Quarters > 3 > balance Sheet > total Assets
8438211
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
59807
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
219512
Quarters > 3 > balance Sheet > equity
8218699
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2181610
Quarters > 3 > cash Flow > depreciation
372794
Quarters > 3 > cash Flow > change In Working Capital
-292682
Quarters > 3 > cash Flow > cash From Operations
-2000843
Quarters > 3 > cash Flow > capital Expenditures
2688
Quarters > 3 > cash Flow > cash From Investing
2621312
Quarters > 3 > cash Flow > cash From Financing
51141
Quarters > 3 > cash Flow > net Change In Cash
1396440
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.000002258973156065838
Quarters > 3 > ratios > PB
1957.7470416132771
Quarters > 3 > ratios > ROE
-0.013590958861007077
Quarters > 3 > ratios > ROA
-0.013237403046688452
Quarters > 3 > ratios > FCF
-2003531
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
392743
Annuals > 0 > income Statement > gross Profit
-392743
Annuals > 0 > income Statement > operating Expenses
3377242
Annuals > 0 > income Statement > operating Income
-3769985
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-3584213
Annuals > 0 > income Statement > net Income
-3584213
Annuals > 0 > income Statement > eps
-0.007248318297970801
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
494488908
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-3191472
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
185772
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
2419115
Annuals > 0 > balance Sheet > short Term Investments
2477900
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4902813
Annuals > 0 > balance Sheet > property Plant Equipment
759819
Annuals > 0 > balance Sheet > total Assets
5755582
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
312780
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
895308
Annuals > 0 > balance Sheet > equity
4860274
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-3584213
Annuals > 0 > cash Flow > depreciation
392743
Annuals > 0 > cash Flow > change In Working Capital
18858
Annuals > 0 > cash Flow > cash From Operations
-3113576
Annuals > 0 > cash Flow > capital Expenditures
152693
Annuals > 0 > cash Flow > cash From Investing
2686216
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-542120
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.007248318297970801
Annuals > 0 > ratios > PB
2751.075365775674
Annuals > 0 > ratios > ROE
-73.74508103864103
Annuals > 0 > ratios > ROA
-62.27368492013492
Annuals > 0 > ratios > FCF
-3266269
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
745588
Annuals > 1 > income Statement > gross Profit
-745588
Annuals > 1 > income Statement > operating Expenses
3991138
Annuals > 1 > income Statement > operating Income
-4736726
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-4363221
Annuals > 1 > income Statement > net Income
-4301837
Annuals > 1 > income Statement > eps
-0.008699562175012427
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
494488908
Annuals > 1 > income Statement > income Tax Expense
312126
Annuals > 1 > income Statement > EBITDA
-3617628
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
373505
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2961235
Annuals > 1 > balance Sheet > short Term Investments
5000000
Annuals > 1 > balance Sheet > receivables
152778
Annuals > 1 > balance Sheet > inventories
-152778
Annuals > 1 > balance Sheet > total Current Assets
8114013
Annuals > 1 > balance Sheet > property Plant Equipment
226514
Annuals > 1 > balance Sheet > total Assets
8438211
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
59807
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
219512
Annuals > 1 > balance Sheet > equity
8218699
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4363221
Annuals > 1 > cash Flow > depreciation
745588
Annuals > 1 > cash Flow > change In Working Capital
-585365
Annuals > 1 > cash Flow > cash From Operations
-4001687
Annuals > 1 > cash Flow > capital Expenditures
5376
Annuals > 1 > cash Flow > cash From Investing
5242624
Annuals > 1 > cash Flow > cash From Financing
102282
Annuals > 1 > cash Flow > net Change In Cash
1396440
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.008699562175012427
Annuals > 1 > ratios > PB
1626.8974046038188
Annuals > 1 > ratios > ROE
-52.34206776522659
Annuals > 1 > ratios > ROA
-50.98043886316661
Annuals > 1 > ratios > FCF
-4007063
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
769687
Annuals > 2 > income Statement > gross Profit
-769687
Annuals > 2 > income Statement > operating Expenses
6273671
Annuals > 2 > income Statement > operating Income
-6273671
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-6062329
Annuals > 2 > income Statement > net Income
-5871130
Annuals > 2 > income Statement > eps
-0.011873127799258948
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
494488908
Annuals > 2 > income Statement > income Tax Expense
-191199
Annuals > 2 > income Statement > EBITDA
-5292644
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
211342
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1564795
Annuals > 2 > balance Sheet > short Term Investments
10000000
Annuals > 2 > balance Sheet > receivables
56548
Annuals > 2 > balance Sheet > inventories
-56548
Annuals > 2 > balance Sheet > total Current Assets
11621343
Annuals > 2 > balance Sheet > property Plant Equipment
891913
Annuals > 2 > balance Sheet > total Assets
12621755
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
438263
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
632320
Annuals > 2 > balance Sheet > equity
12030333
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5871130
Annuals > 2 > cash Flow > depreciation
769687
Annuals > 2 > cash Flow > change In Working Capital
-508945
Annuals > 2 > cash Flow > cash From Operations
-4962949
Annuals > 2 > cash Flow > capital Expenditures
27392
Annuals > 2 > cash Flow > cash From Investing
58978
Annuals > 2 > cash Flow > cash From Financing
134913
Annuals > 2 > cash Flow > net Change In Cash
-4852203
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.011873127799258948
Annuals > 2 > ratios > PB
1111.4388996813304
Annuals > 2 > ratios > ROE
-48.802722252160436
Annuals > 2 > ratios > ROA
-46.515955982349524
Annuals > 2 > ratios > FCF
-4990341
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
604397
Annuals > 3 > income Statement > gross Profit
-604397
Annuals > 3 > income Statement > operating Expenses
7617770
Annuals > 3 > income Statement > operating Income
-7617770
Annuals > 3 > income Statement > interest Expense
23215
Annuals > 3 > income Statement > pretax Income
-7594555
Annuals > 3 > income Statement > net Income
-7422728
Annuals > 3 > income Statement > eps
-0.015010909001016459
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
494488908
Annuals > 3 > income Statement > income Tax Expense
-171827
Annuals > 3 > income Statement > EBITDA
-6990153
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
23215
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
6416998
Annuals > 3 > balance Sheet > short Term Investments
10000000
Annuals > 3 > balance Sheet > receivables
27598
Annuals > 3 > balance Sheet > inventories
-27598
Annuals > 3 > balance Sheet > total Current Assets
16444596
Annuals > 3 > balance Sheet > property Plant Equipment
1460020
Annuals > 3 > balance Sheet > total Assets
18018918
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
821974
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
938032
Annuals > 3 > balance Sheet > equity
17065498
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7445943
Annuals > 3 > cash Flow > depreciation
604397
Annuals > 3 > cash Flow > change In Working Capital
-1024071
Annuals > 3 > cash Flow > cash From Operations
-5267055
Annuals > 3 > cash Flow > capital Expenditures
780876
Annuals > 3 > cash Flow > cash From Investing
-10780875
Annuals > 3 > cash Flow > cash From Financing
22405516
Annuals > 3 > cash Flow > net Change In Cash
6357585
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.015010909001016459
Annuals > 3 > ratios > PB
783.5095156508178
Annuals > 3 > ratios > ROE
-43.49552529905661
Annuals > 3 > ratios > ROA
-41.19408279675839
Annuals > 3 > ratios > FCF
-6047931
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.00349977516583648
Valuation > metrics > PB
3310.6506065954304
Valuation > final Score
20
Valuation > verdict
110255.0% Overvalued
Profitability > metrics > ROE
-35.6070460225082
Profitability > metrics > ROA
-35.29810335413568
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.18420936762001483
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
15.67495683867255
Liquidity > metrics > Quick Ratio
15.67495683867255
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-43
Prev Risks > 1
-216
Prev Risks > 2
-35
Prev Liquidities > 0
50
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:28:59.013Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-06-02
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-18
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-10-25
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-10-31
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.3
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.3
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-06-02
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.29
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.29
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-10-29
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.11
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-26
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-33.38
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-33.38
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-12-31
Earnings History > 8 > report Date
2021-03-31
Earnings History > 8 > date
2020-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0506
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0506
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-09-30
Earnings History > 9 > report Date
2020-12-31
Earnings History > 9 > date
2020-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0167
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0167
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-06-30
Earnings History > 10 > report Date
2020-09-30
Earnings History > 10 > date
2020-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0167
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0167
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-03-31
Earnings History > 11 > report Date
2020-06-30
Earnings History > 11 > date
2020-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0257
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0257
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-12-31
Earnings History > 12 > report Date
2020-03-31
Earnings History > 12 > date
2019-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0257
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0257
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-09-30
Earnings History > 13 > report Date
2019-12-31
Earnings History > 13 > date
2019-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0149
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0149
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-06-30
Earnings History > 14 > report Date
2019-09-30
Earnings History > 14 > date
2019-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0149
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0149
Earnings History > 14 > surprise Percent
-
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARegencell Bioscience (NASDAQ:RGC) Trading Down 7.8% - What's Next? MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.22% of the total shares of Regencell Bioscience Holdings Ltd
1.
Geode Capital Management, LLC(0.0791%)
since
2025/06/30
2.
Fidelity Nasdaq Composite Index(0.0593%)
since
2025/07/31
3.
Fidelity Nasdaq Composite ETF(0.0242%)
since
2025/08/29
4.
Squarepoint Ops LLC(0.0202%)
since
2025/06/30
5.
Schonfeld Strategic Advisors LLC(0.0105%)
since
2025/06/30
6.
BNP Paribas Arbitrage, SA(0.0091%)
since
2025/06/30
7.
UBS Group AG(0.0076%)
since
2025/06/30
8.
Morgan Stanley - Brokerage Accounts(0.0067%)
since
2025/06/30
9.
Y-Intercept (Hong Kong) Ltd(0.0026%)
since
2025/06/30
10.
Greenfield Savings Bank(0.0022%)
since
2025/06/30
11.
BlackRock Inc(0.0017%)
since
2025/06/30
12.
Advisor Group Holdings, Inc.(0%)
since
2025/06/30
13.
Bank of America Corp(0%)
since
2025/06/30
14.
Citigroup Inc(0%)
since
2025/06/30
15.
Royal Bank of Canada(0%)
since
2025/06/30
16.
Tower Research Capital LLC(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.